Dysmetabolic Hepatosiderosis

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-03-27
Clinical Trial Update: Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis. [Phase 2]
A Phase 2 clinical trial evaluating how serum hepcidin responds to iron intake to help differentiate ferroportin disease from dysmetabolic h…